148 related articles for article (PubMed ID: 11025865)
1. Concentrations of follicle-stimulating hormone correlate with alkaline phosphatase and a marker for vitamin K status in the perimenopause.
Lukacs JL; Reame NE
J Womens Health Gend Based Med; 2000 Sep; 9(7):731-9. PubMed ID: 11025865
[TBL] [Abstract][Full Text] [Related]
2. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.
Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Miura M; Irahara M
J Endocrinol Invest; 2006 Nov; 29(10):913-8. PubMed ID: 17185901
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reproductive hormonal dynamics in the perimenopause.
Santoro N; Brown JR; Adel T; Skurnick JH
J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
[TBL] [Abstract][Full Text] [Related]
4. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
5. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.
Sowers MR; Greendale GA; Bondarenko I; Finkelstein JS; Cauley JA; Neer RM; Ettinger B
Osteoporos Int; 2003 May; 14(3):191-7. PubMed ID: 12730778
[TBL] [Abstract][Full Text] [Related]
6. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
[TBL] [Abstract][Full Text] [Related]
7. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
8. [Bone metabolism, bone density and estrogen levels in perimenopause: a prospective 2-year-study].
Seifert-Klauss V; Laakmann J; Rattenhuber J; Höss C; Luppa P; Kiechle M
Zentralbl Gynakol; 2005 Jun; 127(3):132-9. PubMed ID: 15915390
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of undercarboxylated osteocalcin].
Yasui T; Yamada M; Irahara M
Clin Calcium; 2007 Nov; 17(11):1709-16. PubMed ID: 17982191
[TBL] [Abstract][Full Text] [Related]
10. Changes in bone mass during the perimenopausal transition in naturally menopausal cynomolgus monkeys.
Kittivanichkul D; Watanabe G; Nagaoka K; Malaivijitnond S
Menopause; 2016 Jan; 23(1):87-99. PubMed ID: 26671190
[TBL] [Abstract][Full Text] [Related]
11. Appendicular lean mass is lower in late compared with early perimenopausal women: potential role of FSH.
Park YM; Jankowski CM; Ozemek C; Hildreth KL; Kohrt WM; Moreau KL
J Appl Physiol (1985); 2020 May; 128(5):1373-1380. PubMed ID: 32298212
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.
Perrien DS; Achenbach SJ; Bledsoe SE; Walser B; Suva LJ; Khosla S; Gaddy D
J Clin Endocrinol Metab; 2006 May; 91(5):1848-54. PubMed ID: 16449331
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women.
Chapurlat RD; Garnero P; Sornay-Rendu E; Arlot ME; Claustrat B; Delmas PD
Osteoporos Int; 2000; 11(6):493-8. PubMed ID: 10982164
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
Gambacciani M; Ciaponi M; Cappagli B; Benussi C; Genazzani AR
Osteoporos Int; 2000; 11(6):544-8. PubMed ID: 10982172
[TBL] [Abstract][Full Text] [Related]
15. Bone loss in premenopausal, perimenopausal and postmenopausal women: results of a prospective observational study over 9 years.
Seifert-Klauss V; Fillenberg S; Schneider H; Luppa P; Mueller D; Kiechle M
Climacteric; 2012 Oct; 15(5):433-40. PubMed ID: 22443333
[TBL] [Abstract][Full Text] [Related]
16. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN).
Luetters C; Huang MH; Seeman T; Buckwalter G; Meyer PM; Avis NE; Sternfeld B; Johnston JM; Greendale GA
J Womens Health (Larchmt); 2007 Apr; 16(3):331-44. PubMed ID: 17439378
[TBL] [Abstract][Full Text] [Related]
17. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
18. Lumbar and femoral bone density in perimenopausal women with irregular cycles.
Perrone G; Galoppi P; Capri O; Anelli G; Borrello M; Zichella L
Int J Fertil Menopausal Stud; 1995; 40(3):120-5. PubMed ID: 7663538
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
Gambacciani M; Cappagli B; Ciaponi M; Benussi C; Genazzani AR
Menopause; 1999; 6(1):43-8. PubMed ID: 10100179
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea.
Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF
J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
